Style | Citing Format |
---|---|
MLA | Jahanbani Mazraeh E, et al.. "Assessment of Thyme Honey Oral Gel for the Prevention of Adriamycin and Cyclophosphamide Chemotherapy-Induced Oral Mucositis in Patients With Breast Cancer." Supportive Care in Cancer, vol. 31, no. 8, 2023, pp. -. |
APA | Jahanbani Mazraeh E, Sadighi S, Manifar S, Bakhshandeh H, Rajabi M (2023). Assessment of Thyme Honey Oral Gel for the Prevention of Adriamycin and Cyclophosphamide Chemotherapy-Induced Oral Mucositis in Patients With Breast Cancer. Supportive Care in Cancer, 31(8), -. |
Chicago | Jahanbani Mazraeh E, Sadighi S, Manifar S, Bakhshandeh H, Rajabi M. "Assessment of Thyme Honey Oral Gel for the Prevention of Adriamycin and Cyclophosphamide Chemotherapy-Induced Oral Mucositis in Patients With Breast Cancer." Supportive Care in Cancer 31, no. 8 (2023): -. |
Harvard | Jahanbani Mazraeh E et al. (2023) 'Assessment of Thyme Honey Oral Gel for the Prevention of Adriamycin and Cyclophosphamide Chemotherapy-Induced Oral Mucositis in Patients With Breast Cancer', Supportive Care in Cancer, 31(8), pp. -. |
Vancouver | Jahanbani Mazraeh E, Sadighi S, Manifar S, Bakhshandeh H, Rajabi M. Assessment of Thyme Honey Oral Gel for the Prevention of Adriamycin and Cyclophosphamide Chemotherapy-Induced Oral Mucositis in Patients With Breast Cancer. Supportive Care in Cancer. 2023;31(8):-. |
BibTex | @article{ author = {Jahanbani Mazraeh E and Sadighi S and Manifar S and Bakhshandeh H and Rajabi M}, title = {Assessment of Thyme Honey Oral Gel for the Prevention of Adriamycin and Cyclophosphamide Chemotherapy-Induced Oral Mucositis in Patients With Breast Cancer}, journal = {Supportive Care in Cancer}, volume = {31}, number = {8}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Jahanbani Mazraeh E AU - Sadighi S AU - Manifar S AU - Bakhshandeh H AU - Rajabi M TI - Assessment of Thyme Honey Oral Gel for the Prevention of Adriamycin and Cyclophosphamide Chemotherapy-Induced Oral Mucositis in Patients With Breast Cancer JO - Supportive Care in Cancer VL - 31 IS - 8 SP - EP - PY - 2023 ER - |